Company Registration No. 12884721 (England and Wales)
Pharma Key Ltd
Unaudited accounts
for the year ended 30 September 2025
Pharma Key Ltd
Unaudited accounts
Contents
Pharma Key Ltd
Company Information
for the year ended 30 September 2025
Directors
Anzal Suleman Ali
Zia Mohyiadin Khan
Company Number
12884721 (England and Wales)
Registered Office
Office 1 Izabella House
24-26 Regent Place
Birmingham
West Midlands
B1 3NJ
England
Accountants
Linktax Limited
11A Snow Hill
Stoke-on-Trent
Staffordshire
ST1 4LU
Pharma Key Ltd
Statement of financial position
as at 30 September 2025
Cash at bank and in hand
9,919
63,781
Creditors: amounts falling due within one year
(57,979)
(117,082)
Net current assets
78,940
49,049
Total assets less current liabilities
78,940
49,049
Creditors: amounts falling due after more than one year
(56,714)
-
Called up share capital
100
100
Profit and loss account
22,126
48,949
Shareholders' funds
22,226
49,049
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2026 and were signed on its behalf by
Zia Mohyiadin Khan
Director
Company Registration No. 12884721
Pharma Key Ltd
Notes to the Accounts
for the year ended 30 September 2025
Pharma Key Ltd is a private company, limited by shares, registered in England and Wales, registration number 12884721. The registered office is Office 1 Izabella House, 24-26 Regent Place, Birmingham, West Midlands, B1 3NJ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial tiabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid. in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Pharma Key Ltd
Notes to the Accounts
for the year ended 30 September 2025
Provisions (le liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
4
Average number of employees
During the year the average number of employees was 3 (2024: 2).